8-K
Current Report
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-23-072192
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading rare-20231215.htm…